Table 3.
Outcome № of participants (studies) |
Relative effect (95% CI) |
Anticipated absolute effects (95% CI) | Certainty | ||
---|---|---|---|---|---|
Difference | |||||
HIV infection № of participants: 149 (1 RCT) |
RR 0.07 (0.00 to 1.38) |
6.0% |
0.4% (0 to 8.3) |
5.6% fewer (6 fewer to 2.3 more) |
⨁⨁◯◯ LOW a |
Any STI № of participants: 2232 (3 RCTs) |
RR 0.74 (0.62 to 0.89) |
24.9% |
18.4% (15.5 to 22.2) |
6.5% fewer (9.5 fewer to 2.7 fewer) |
⨁⨁⨁◯ MODERATE b |
Gonorrhoea № of participants: 790 (2 RCTs) |
RR 0.59 (0.41 to 0.86) |
15.2% |
9.0% (6.2 to 13.1) |
6.2% fewer (9 fewer to 2.1 fewer) |
⨁⨁⨁⨁ HIGH |
Chlamydia № of participants: 790 (2 RCTs) |
RR 0.67 (0.47 to 0.94) |
16.0% |
10.7% (7.5 to 15) |
5.3% fewer (8.5 fewer to 1 fewer) |
⨁⨁⨁⨁ HIGH |
Trichomonas № of participants: 790 (2 RCTs) |
RR 1.01 (0.63 to 1.60) |
8.0% |
8.1% (5 to 12.8) |
0.1% more (3 fewer to 4.8 more) |
⨁⨁⨁◯ MODERATE a |
Genital ulcer disease № of participants: 457 (1 RCT) |
RR 4.72 (0.23 to 97.87) | 0.0% |
0.0% (0 to 0) |
0.0% fewer (0 fewer to 0 fewer) |
⨁⨁⨁◯ MODERATE a |
CI Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
Explanations
aIncludes only one study with small sample size and wide confidence intervals
bHigh risk of selection bias due to lack of proper randomization in one of the trials